Ranbaxy may lose $140 mn on US ban

Ranbaxy may lose $140 mn on US ban

Ranbaxy Laboratories, Indias biggest drugmaker, may lose as much as 0 million of revenue in 2009 after the US drug regulator blocked sale of more than 30 generic medicines and 7 APIs made in

Ranbaxy may lose $140 mn on US ban

USFDA bans 30 Ranbaxy generic drugs

Ban on export of nonbasmati rice extended till Nov

Ban on export of nonbasmati rice extended till Nov

Ban on export of nonbasmati rice extended till Nov

This entry was posted on Tuesday, September 23rd, 2008 at 4:10 am and is filed under Business Standard. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply